Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
A Systematic Approach to Hepatic Complications in Hematopoietic Stem Cell Transplantation
2002
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Leishmaniasis
2018 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Ribosome-inactivating proteins from plants
1993
Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia
2004
Review article: management of hepatic disease following haematopoietic cell transplant
2006
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease
2001
Lectins as Plant Defense Proteins
1995 Standout
Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial
2002 Standout
Vascular disorders of the liver # †
2008 Standout
Ciprofloxacin vs an Aminoglycoside in Combination With a β-Lactam for the Treatment of Febrile Neutropenia: A Meta-analysis of Randomized Controlled Trials
2005
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Chronic graft-versus-host disease
2003 Standout
Cancer genes and the pathways they control
2004 Standout
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
2012
Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment
2003
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience
2006
Development and validation of a scale to measure symptoms of chronic graft-versus-host disease
2002
Acute kidney injury
2021 Standout
Graft-versus-host disease
2009 Standout
The Threshold for Prophylactic Platelet Transfusions in Adults with Acute Myeloid Leukemia
1997
Biology and management of relapsed acute myeloid leukaemia
2005
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Chronic Myelogenous Leukemia
2002
Renal impairment and Amphotericin B formulations in patients with invasive fungal infections
2008
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients
2001
A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger
2002
Idarucizumab for Dabigatran Reversal
2015 Standout
A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
2006
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
2002
Guidelines for the use of platelet transfusions
2016
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Disseminated Intravascular Coagulation
1999 Standout
The changing epidemiology of acute renal failure
2006
Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients
2007
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Aspects Concerning Busulfan Pharmacokinetics and Bioavailability
1996
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation†
2005
Overview of Platelet Transfusion
2010
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial
2000
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams
2010
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review
2007
Effect of Age and Previous Autologous Transplantation on Nonrelapse Mortality and Survival in Patients Treated With Reduced-Intensity Conditioning and Allografting for Advanced Hematologic Malignancies
2005
Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors
2004
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Long-term outcome of hepatitis C infection after bone marrow transplantation
2003
Advances in leishmaniasis
2005 Standout
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Should myeloid and lymphoid neoplasms with PCM 1‐JAK 2 and other rearrangements of JAK 2 be recognized as specific entities?
2014
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
HOW NEUTROPHILS KILL MICROBES
2005 Standout
Plant Lectins: A Composite of Several Distinct Families of Structurally and Evolutionary Related Proteins with Diverse Biological Roles
1998 Standout
Recommendations for the transfusion of plasma and platelets.
2009
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
2000
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
2001
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia
2004
Works of Á Figuera being referenced
Selective T cell subset depletion with anti-CD4 and anti-CD8 intact ricin immunotoxins.
1988
Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution.
1996
Initial empiric therapy of febrile neutropenia with antibiotic monotherapy. Piperacillin/tazobactam versus imipenem/cilastatin (1994-1996)
2001
Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
1995
Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia
1998
Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients
2000
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients
2002
Transforming and Tumorigenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosine-Kinase
2012
Acute Renal Failure in Patients following Bone Marrow Transplantation: Prevalence, Risk Factors and Outcome
1995
High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
1998
High dose busulfan and seizures.
1991
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
1996
[Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
1997
Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome.
1996
Allogeneic hematopoietic stem cell transplantation in patients 50 years of age and older.
2002
Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation.
2000
Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
1998
Visceral leishmaniasis (kala-azar) complicating acute leukaemia
1983
Estudio comparativo de piperacilina/tazobactam frente a imipenem/cilastatina en la neutropenia febril (1994–1996)
2001